Statin monotherapy reduced cholesterol and bile acid synthesis biomarkers , ezetimibe reduced - sitosterol ( sterol absorption marker ) , and combination therapy achieved additive reductions in lipoprotein-associated phospholipase A2 mass and activity , free cholesterol and 7-ketocholesterol .